The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Research-Grade Proteins Market During The 2026–2030 Period?
The research-grade proteins market size has experienced substantial growth in recent years. This market is set to expand from $1.33 billion in 2025 to $1.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 20.8%. The historical growth of this market can be attributed to various factors, such as the increase in academic life sciences research, the growing utilization of proteins in molecular biology experiments, the expansion of biopharmaceutical research and development activities, the accessibility of recombinant protein expression systems, and the rising investment in fundamental biomedical research.
The research-grade proteins market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $3.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.6%. Several factors are set to drive this growth during the forecast period, including an intensified focus on precision medicine research, a growing need for protein-based drug targets, advancements in cell and gene therapy research, the broader application of proteins in structural biology, and the increasing trend of pharmaceutical companies outsourcing their research endeavors. Key trends anticipated over the forecast timeframe encompass an escalating demand for high-purity proteins in drug discovery, the expanded utilization of recombinant proteins in cell and molecular biology investigations, wider integration of research-grade proteins in immunology and oncology studies, the broadening scope of protein-based assays and functional analyses, and a stronger inclination towards custom and application-specific proteins.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp
What Influential Factors Are Boosting The Research-Grade Proteins Market Demand?
The escalating number of clinical trials is anticipated to stimulate the expansion of the research-grade proteins market. Clinical trials are investigative studies focused on evaluating the safety and effectiveness of new medical treatments, interventions, or devices in humans. The increase in these trials stems from advancements in medical research, the existing burden of diseases, shifts in regulatory policies, patient demand, and industry investment. Research-grade proteins play a vital role in clinical trials by serving as indispensable tools for developing biomarkers, formulating assays, pinpointing drug targets, ensuring quality control, and setting reference standards, thus confirming the accuracy and reliability of experimental results. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, indicated that the number of pharmaceutical industry trials launched in the UK rose for the second consecutive year, climbing from 411 in 2022 to 426 in 2023. Therefore, the increasing volume of clinical trials is driving the growth of the research-grade proteins market.
How Does Segment Analysis Break Down The Research-Grade Proteins Market Structure?
The research-grade proteins market covered in this report is segmented –
1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells
3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses
Subsegments:
1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor
2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies
3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens
5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases
6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers
7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline
8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins
What Trends Are Shaping The Research-Grade Proteins Market Structure?
Leading companies in the research-grade proteins market are focused on creating innovative solutions, including high-purity, animal-origin-free recombinant proteins, to improve consistency, safety, and performance in advanced cell and gene therapy processes. These high-purity, animal-origin-free recombinant proteins are laboratory-produced without any animal-derived materials and are purified to stringent standards, guaranteeing uniformity, safety, and dependability for both research and therapeutic uses. For instance, in October 2025, Qkine Ltd., a UK-based manufacturing firm, launched a new range of Cell Therapy Grade recombinant proteins specifically designed to fulfill the exacting requirements of cell therapy research, process development, and GMP manufacturing. These particular high-purity, animal-origin-free proteins feature low endotoxin levels and minimal host cell contaminants, produced according to defined manufacturing standards with complete regulatory documentation. Their reliable performance supports effortless scalability from initial research stages to GMP clinical workflows. Intended for sophisticated applications such as CAR-T, iPSC differentiation, and ex vivo gene editing, these regulatory-ready proteins help expedite therapy development while minimizing risks.
Who Are The Firms Contributing To The Research-Grade Proteins Market Ecosystem?
Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)
Access The Complete Research-Grade Proteins Market Report:
https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report
What Is The Largest Regional Market In The Research-Grade Proteins Market?
North America was the largest region in the research-grade proteins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Research-Grade Proteins Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp
Browse Through More Reports Similar to the Global Research-Grade Proteins Market 2026, By The Business Research Company
Research Grade Proteins Market Report 2026
https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report
Protein Assays Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-assays-global-market-report
Protein Engineering Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-engineering-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model